• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Zoetis hints at new monoclonal antibody for osteoarthritis pain

September 25, 2019
dvm360, dvm360 November 2019, Volume 50, Issue 11

Activities at the WSAVA Conference in Toronto focused on the role of nerve growth factor in pain pathway for dogs and cats.

Zoetis recently alluded to a new monoclonal antibody product in the works that could provide long-lasting osteoarthritis (OA) pain control in veterinary patients by targeting nerve growth factor (NGF) in the pain pathway. At the 2019 World Small Animal Veterinary Association (WSAVA) Conference in Toronto in July, the company supported several presentations related to research and development in chronic OA pain, according to a Zoetis release.

Highlights of Zoetis' OA-related activities at the conference included: 

Advertisement
  • Interactive website. Zoetis has launched a website for veterinarians, TheNewScienceofOsteoarthritisPain.com, highlighting the science and tools that support the diagnosis and treatment of OA in cats and dogs. It features videos focused on conducting a successful OA exam, since it's estimated that 38% of all cats have clinical signs of OA and the prevalence of OA in dogs is believed to be greater than 20%, according to the website. 
  • Data related to chronic OA and NGF. Key opinion leaders Duncan Lascelles, BVSc, PhD, MRCVS, CertVA, DSAS(ST), DECVS, DACVS, and Margaret E. Gruen, DVM, MVPH, PhD, DACVB, both of the North Carolina State University College of Veterinary Medicine, presented findings on the following subjects:
  • Nerve growth factor, pain and monoclonal antibodies for chronic pain 
  • Identifying and measuring OA pain in young dogs 
  • dentifying OA pain in cats
  • Quality of life assessment in cats with chronic OA pain.

“We look forward to discussing the central role of NGF as a driver of osteoarthritis pain,” says Dr. Lascelles in the release. “With new approaches and a novel pain pathway on the horizon, we have an opportunity to significantly advance the way we manage osteoarthritis pain for feline and canines.” 

download issueDownload Issue: dvm360 November 2019

Related Content:

Pain ManagementProductsOrthopedicsBreaking Newsdvm360 November 2019
New Hawaii-based pet CBD brand launches
New Hawaii-based pet CBD brand launches
Updated EquiTrace app integrates wth HISA Portal
Updated EquiTrace app integrates wth HISA Portal
Tips and tricks for diagnosing canine osteoarthritis early
Tips and tricks for diagnosing canine osteoarthritis early

Advertisement

Latest News

Managing wounds in pet patients

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

View More Latest News
Advertisement